The Effect of Remote Ischemic Preconditioning on Kidney Function in Patients Undergoing Partial Nephrectomy

October 20, 2021 updated by: Won Ho Kim, MD, Seoul National University Hospital

The Effect of Remote Ischemic Preconditioning on Kidney Function in Patients Undergoing Partial Nephrectomy : A Randomized Controlled Trial

This study is intended to evaluate the renal protective effect of Remote Ischemic Preconditioning (RIPC) in patients undergoing partial nephrectomy. Half of the enrolled subjects will receive 4 cycles of brief ischemia on the upper arm after anesthesia induction and prior to the surgery, while the other half will not receive this treatment as a control group.

Study Overview

Detailed Description

Remote Ischemic Preconditioning (RIPC) is the concept of mitigating ischemia-reperfusion injury to target organs by a brief episode of ischemia-reperfusion of the limb. The protective effect of RIPC on major organs has been demonstrated in an animal study, but its clinical efficacy has not yet been established.

The kidney is a typical organ vulnerable to ischemic injury, and the renal protective effect of RIPC can be expected. There have been many reports of renal protective effects of RIPC in cardiac and vascular surgery. On the other hand, few studies have investigated the effect of RIPC during partial nephrectomy in which ischemia-reperfusion injury can occur during the surgery.

In this study, the investigators will evaluate the effect of RIPC in patients undergoing partial nephrectomy to prevent renal impairment and improve the prognosis after the surgery.

Study Type

Interventional

Enrollment (Actual)

86

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Adult patients scheduled to undergo open, laparoscopic, or robot-assisted laparoscopic partial nephrectomy
  • Normal contralateral renal function was defined as split renal function of >40% as determined by preoperative Tc-99m DiethyleneTriamine Pentaacetic Acid (DTPA) kidney scan
  • Written informed consent

Exclusion Criteria:

  • Peripheral vascular disease involving upper extremities or lower extremities
  • Severe cardiopulmonary diseases (valvular or ischemic heart disease, heart failure, chronic obstructive pulmonary disease)
  • Hepatic failure, renal failure

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Remote Ischemic Preconditioning (RIPC)
Four cycles of upper arm ischemia/reperfusion
After induction of anesthesia, RIPC consisted of four 5-min cycles of limb ischemia induced by a blood pressure cuff placed on the upper arm and inflated to 250 mmHg, with an intervening 5 min of reperfusion during which the cuff was deflated.
Other Names:
  • RIPC
Sham Comparator: Sham control
Placement of a blood pressure cuff around upper arm without inflation.
After induction of anesthesia, sham control consisted of the placement of a blood pressure cuff on the upper arm with no inflation during the surgery.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Serum creatinine level
Time Frame: Postoperative day 1
Postoperative serum creatinine levels as an index of kidney damage
Postoperative day 1

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The incidence of acute kidney injury (AKI)
Time Frame: Within 7 days after surgery
The incidence of AKI according to the serum creatinine diagnostic criteria of Kidney Disease Improving Global outcomes (KDIGO) Clinical Practice Guideline for AKI
Within 7 days after surgery
Serum creatinine level
Time Frame: 1 hour after surgery
Postoperative serum creatinine levels as an index of kidney damage
1 hour after surgery
Serum creatinine level
Time Frame: Postoperative day 3
Postoperative serum creatinine levels as an index of kidney damage
Postoperative day 3
Serum creatinine level
Time Frame: 2 weeks after surgery
Postoperative serum creatinine levels as an index of kidney damage
2 weeks after surgery
estimated glomerular filtration rate (eGFR)
Time Frame: 1 hour after surgery
eGFR is obtained by the formula of Isotope Dilution Mass Spectrometry (IDMS) Modification of Diet in Renal Disease (MDRD).
1 hour after surgery
estimated glomerular filtration rate (eGFR)
Time Frame: Postoperative day 1
eGFR is obtained by the formula of Isotope Dilution Mass Spectrometry (IDMS) Modification of Diet in Renal Disease (MDRD).
Postoperative day 1
estimated glomerular filtration rate (eGFR)
Time Frame: Postoperative day 3
eGFR is obtained by the formula of Isotope Dilution Mass Spectrometry (IDMS) Modification of Diet in Renal Disease (MDRD).
Postoperative day 3
estimated glomerular filtration rate (eGFR)
Time Frame: 2 weeks after surgery
eGFR is obtained by the formula of Isotope Dilution Mass Spectrometry (IDMS) Modification of Diet in Renal Disease (MDRD).
2 weeks after surgery
Regional oxygen saturation (rSO2) of the contralateral kidney of the operated side
Time Frame: 5 min after the induction of anesthesia (baseline)
Renal rSO2 of the contralateral kidney of the operated side is monitored with Near-infrared spectroscopy.
5 min after the induction of anesthesia (baseline)
Regional oxygen saturation (rSO2) of the contralateral kidney of the operated side
Time Frame: 30 minutes after induction of anesthesia
Renal rSO2 of the contralateral kidney of the operated side is monitored with Near-infrared spectroscopy.
30 minutes after induction of anesthesia
Regional oxygen saturation (rSO2) of the contralateral kidney of the operated side
Time Frame: 60 minutes after induction of anesthesia
Renal rSO2 of the contralateral kidney of the operated side is monitored with Near-infrared spectroscopy.
60 minutes after induction of anesthesia
Regional oxygen saturation (rSO2) of the contralateral kidney of the operated side
Time Frame: 90 minutes after induction of anesthesia
Renal rSO2 of the contralateral kidney of the operated side is monitored with Near-infrared spectroscopy.
90 minutes after induction of anesthesia
Urine creatinine level
Time Frame: Postoperative day 1
Urine creatinine level
Postoperative day 1
Urine creatinine level
Time Frame: 2 weeks after surgery
Urine creatinine level
2 weeks after surgery
Urine microalbumin
Time Frame: Postoperative day 1
Urine microalbumin
Postoperative day 1
Urine microalbumin
Time Frame: 2 weeks after surgery
Urine microalbumin
2 weeks after surgery
Urine beta-2 microglobulin
Time Frame: Postoperative day 1
Urine beta-2 microglobulin
Postoperative day 1
Urine beta-2 microglobulin
Time Frame: 2 weeks after surgery
Urine beta-2 microglobulin
2 weeks after surgery
Urine N-acetyl-beta-D-glucosaminidase
Time Frame: Postoperative day 1
Urine N-acetyl-beta-D-glucosaminidase
Postoperative day 1
Urine N-acetyl-beta-D-glucosaminidase
Time Frame: 2 weeks after surgery
Urine N-acetyl-beta-D-glucosaminidase
2 weeks after surgery
Glomerular filtration rate measured by scintigraphy
Time Frame: preoperative baseline
Glomerular filtration rate measured by technetium diethylene triamine pentacetic acid (99mTc-DTPA) radionuclide scintigraphy
preoperative baseline
Glomerular filtration rate measured by scintigraphy
Time Frame: 6 months after surgery
Glomerular filtration rate measured by technetium diethylene triamine pentacetic acid (99mTc-DTPA) radionuclide scintigraphy
6 months after surgery
Glomerular filtration rate measured by scintigraphy
Time Frame: 12 months after surgery
Glomerular filtration rate measured by technetium diethylene triamine pentacetic acid (99mTc-DTPA) radionuclide scintigraphy
12 months after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Won Ho Kim, MD, PhD, Seoul National University Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2017

Primary Completion (Actual)

August 28, 2018

Study Completion (Actual)

August 28, 2018

Study Registration Dates

First Submitted

September 3, 2017

First Submitted That Met QC Criteria

September 3, 2017

First Posted (Actual)

September 6, 2017

Study Record Updates

Last Update Posted (Actual)

October 21, 2021

Last Update Submitted That Met QC Criteria

October 20, 2021

Last Verified

October 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Renal Neoplasm

Clinical Trials on Remote Ischemic Preconditioning

3
Subscribe